These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34848739)

  • 1. Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model.
    Mahdevar E; Kefayat A; Safavi A; Behnia A; Hejazi SH; Javid A; Ghahremani F
    Sci Rep; 2021 Nov; 11(1):23121. PubMed ID: 34848739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine.
    Safavi A; Kefayat A; Sotoodehnejadnematalahi F; Salehi M; Modarressi MH
    Int Immunopharmacol; 2019 Nov; 76():105872. PubMed ID: 31499268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model.
    Safavi A; Kefayat A; Mahdevar E; Ghahremani F; Nezafat N; Modarressi MH
    Hum Vaccin Immunother; 2021 Jan; 17(1):22-34. PubMed ID: 32497486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Humoral and Cellular Immune Responses in Mice by Multiepitope Vaccines Composing of Both T and B Lymphocyte Epitopes of MAGE-A3 which are Recombined into HBcAg.
    Chen Q; Li W; Wang P; Shao H; Ding Y; Wang W; Cen D; Cai Y; Xue X; Zhang L; Zhu G
    Protein Pept Lett; 2017; 24(10):947-954. PubMed ID: 28641561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches.
    Mahdevar E; Safavi A; Abiri A; Kefayat A; Hejazi SH; Miresmaeili SM; Iranpur Mobarakeh V
    J Biomol Struct Dyn; 2022 Sep; 40(14):6363-6380. PubMed ID: 33599191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.
    NoeDominguez-Romero A; Zamora-Alvarado R; Servín-Blanco R; Pérez-Hernández EG; Castrillon-Rivera LE; Munguia ME; Acero G; Govezensky T; Gevorkian G; Manoutcharian K
    Hum Vaccin Immunother; 2014; 10(11):3201-13. PubMed ID: 25483665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
    Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
    Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics design of a peptide vaccine containing sarcoma antigen NY-SAR-35 epitopes against breast cancer and evaluation of its immunological function in BALB/c mouse model.
    Samman N; Mohabatkar H; Behbahani M; Ganjlikhani Hakemi M
    PLoS One; 2024; 19(6):e0306117. PubMed ID: 38923980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP-7 derived peptides with MHC class-I binding motifs from canine mammary tumor tissue elicit strong antigen-specific T-cell responses in BALB/c mice.
    Yadav PK; Gupta SK; Kumar S; Ghosh M; Yadav BS; Kumar D; Kumar A; Saini M; Kataria M
    Mol Cell Biochem; 2021 Jan; 476(1):311-320. PubMed ID: 32970284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of imprinted sites.
    Ghochikyan A; Mkrtichyan M; Loukinov D; Mamikonyan G; Pack SD; Movsesyan N; Ichim TE; Cribbs DH; Lobanenkov VV; Agadjanyan MG
    J Immunol; 2007 Jan; 178(1):566-73. PubMed ID: 17182597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.
    Cecil DL; Holt GE; Park KH; Gad E; Rastetter L; Childs J; Higgins D; Disis ML
    Cancer Res; 2014 May; 74(10):2710-8. PubMed ID: 24778415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.
    Wagner S; Jasinska J; Breiteneder H; Kundi M; Pehamberger H; Scheiner O; Zielinski CC; Wiedermann U
    Breast Cancer Res Treat; 2007 Nov; 106(1):29-38. PubMed ID: 17203384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis.
    Lewēn S; Zhou H; Hu HD; Cheng T; Markowitz D; Reisfeld RA; Xiang R; Luo Y
    Cancer Immunol Immunother; 2008 Apr; 57(4):507-15. PubMed ID: 17786443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
    Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma.
    Safavi A; Kefayat A; Abiri A; Mahdevar E; Behnia AH; Ghahremani F
    Mol Immunol; 2019 Aug; 112():93-102. PubMed ID: 31079006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells
    Cecil DL; Slota M; O'Meara MM; Curtis BC; Gad E; Dang Y; Herendeen D; Rastetter L; Disis ML
    Clin Cancer Res; 2017 Jul; 23(13):3396-3404. PubMed ID: 28039264
    [No Abstract]   [Full Text] [Related]  

  • 17. Complementary antitumor immunity induced by plasmid DNA encoding secreted and cytoplasmic human ErbB-2.
    Piechocki MP; Pilon SA; Wei WZ
    J Immunol; 2001 Sep; 167(6):3367-74. PubMed ID: 11544327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens.
    Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
    Immunol Lett; 2005 Jun; 99(1):85-93. PubMed ID: 15894116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model.
    Rosenthal KS; Stone S; Koski G; Zimmerman DH
    J Immunol Res; 2017; 2017():3613505. PubMed ID: 28459074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice.
    Doosti M; Nassiri M; Nasiri K; Tahmoorespur M; Zibaee S
    Microb Pathog; 2019 Jul; 132():30-37. PubMed ID: 31004723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.